Development of a Collaborative European Post-Authorization Safety Study (PASS) Program Examining Rivaroxaban Use in Routine Clinical Practice

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2014)

引用 23|浏览11
暂无评分
摘要
Development of a Collaborative European Post-Authorization Safety Study (PASS) Program Examining Rivaroxaban Use in Routine Clinical Practice
更多
查看译文
关键词
rivaroxaban use,clinical practice,post-authorization
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要